Walpharma SRL
The score of Walpharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Equity -43 % Total assets -30 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Walpharma's annual accounts
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Net result | −27,936 € | ||||
| Equity | 98,407 € | ||||
| Cash | 49,208 € | ||||
| EBITDA | −7,617 € | ||||
| Total assets | 202,753 € |
Filed annual accounts
- Year ended 31 Dec 2024filed on 31 Aug 2025
- Year ended 31 Dec 2023filed on 29 Aug 2024
- Year ended 31 Dec 2022filed on 27 Feb 2024
- Year ended 31 Dec 2021filed on 27 Sep 2023
- Year ended 31 Dec 2020filed on 27 Sep 2023
Walpharma's financial analysis
- Solvency48.5%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Walpharma
Walpharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0442.452.731
- VAT number
- BE0442452731
- Peppol
- Registered · 0208:0442452731 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 10 Dec 1990
- Registered office
- 6700 Arlon
- Latest accounts
- 2024 · filed on 31 Aug 2025
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Walpharma (SRL) has been based in Arlon since 1990, active in: retail sale of pharmaceutical products. For 2024, it reports a net loss of 27,936 € and equity of 98,407 €; its revenue is not published. Its solvency stands at 48.5%, above the median of its sector (41.5%).
Companies similar to Walpharma
Companies in the same business, of comparable size and area, outside its group.
- LUC Thaens Retail sale of pharmaceutical products Heusden-Zolder · balance sheet 204,672 €
- Pharmacie Chaussee DE Gand Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet 199,651 €
- Apotheek VAN Dionant Retail sale of pharmaceutical products Beersel · balance sheet 229,148 €
- Melbuj Retail sale of pharmaceutical products Wemmel · balance sheet 237,909 €
- Somad Retail sale of pharmaceutical products Frameries · balance sheet 170,686 €
- Ptms Consultancy Retail sale of pharmaceutical products Londerzeel · balance sheet 192,606 €
- Vivapharma Retail sale of pharmaceutical products Auderghem · balance sheet 236,296 €
- I & CM Marbotin Retail sale of pharmaceutical products Schaerbeek · balance sheet 323,588 €
Frequently asked questions about Walpharma
What is the revenue of Walpharma?
Walpharma files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of Walpharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0442452731 for Walpharma, if the company is VAT-registered. Its company number (CBE) is 0442.452.731.
Where is the registered office of Walpharma?
According to the CBE register, the registered office of Walpharma is in 6700 Arlon.
What is the equity of Walpharma?
At the close of the 2024 financial year, the equity of Walpharma amounts to 98,407 €, a solvency of 48.5% of total assets.
Who manages Walpharma?
The register lists 2 active mandates at Walpharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Walpharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →